Beyond LDL-C levels, does remnant cholesterol estimation matter?

Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

(2019) Brian A. Ference et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population

(2019) Anette Varbo et al.   ANNALS OF NEUROLOGY

Remnant cholesterol and coronary atherosclerotic plaque burden assessed by computed tomography coronary angiography

(2019) Andrew Lin et al.   ATHEROSCLEROSIS

Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol

(2019) Xin Su et al.   Lipids in Health and Disease

Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

(2019) Fabian J Brunner et al.   LANCET

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk

(2017) Brian A. Ference et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

(2016) Børge G. Nordestgaard   CIRCULATION RESEARCH

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients

(2016) Stephen J. Nicholls et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of Statins on Serial Coronary Calcification During Atheroma Progression and Regression

(2015) Rishi Puri et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

(2013) Anette Varbo et al.   CIRCULATION

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

(2012) Anette Varbo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY